COPD
... Generally exacerbations present with worsening in baseline dyspnea, increased sputum volume, and/or increase in sputum purulence. Management: ...
... Generally exacerbations present with worsening in baseline dyspnea, increased sputum volume, and/or increase in sputum purulence. Management: ...
Understanding Side Effects of Drug Therapy
... controls that are in place for healthy cells. The accumulation of these cells in the marrow, blood and/or lymphatic tissue interferes with production and functioning of red blood cells, white blood cells and platelets. The disease process can lead to severe anemia, bleeding, an impaired ability to f ...
... controls that are in place for healthy cells. The accumulation of these cells in the marrow, blood and/or lymphatic tissue interferes with production and functioning of red blood cells, white blood cells and platelets. The disease process can lead to severe anemia, bleeding, an impaired ability to f ...
MCQ 2 Which is NOT associated with TTP?
... Central nervous system signs Thrombocytopenia Renal dysfunction ...
... Central nervous system signs Thrombocytopenia Renal dysfunction ...
The relative efficacy of bona fide psychotherapies for treating post
... most efficacious. Importantly, Bisson et al. (2007) urged caution interpreting the conclusion because of the “considerable unexplained heterogeneity observed in these comparisons” (p.13). Estimation of relative efficacy by comparing treatments vis-à-vis controls in meta-analysis introduces significa ...
... most efficacious. Importantly, Bisson et al. (2007) urged caution interpreting the conclusion because of the “considerable unexplained heterogeneity observed in these comparisons” (p.13). Estimation of relative efficacy by comparing treatments vis-à-vis controls in meta-analysis introduces significa ...
Dyspepsia and Gastro-oesophageal Reflux
... from the stomach or duodenum. Dyspepsia is referred to as organic if clinical investigation can trace the symptoms to a demonstrable disease, such as a peptic ulcer or cancer, and functional if it cannot. Heartburn and acid regurgitation are no longer considered to be symptoms of dyspepsia, but of g ...
... from the stomach or duodenum. Dyspepsia is referred to as organic if clinical investigation can trace the symptoms to a demonstrable disease, such as a peptic ulcer or cancer, and functional if it cannot. Heartburn and acid regurgitation are no longer considered to be symptoms of dyspepsia, but of g ...
Asthma (ppt)
... Incidence of acute asthma, defined as the number of persons who develop asthma within a specific time period, is approximately 0.2-0.4% annually. Childhood asthma persists into adulthood in approximately 50% of cases. Those with symptoms persisting into the second decade of life usually have asthma ...
... Incidence of acute asthma, defined as the number of persons who develop asthma within a specific time period, is approximately 0.2-0.4% annually. Childhood asthma persists into adulthood in approximately 50% of cases. Those with symptoms persisting into the second decade of life usually have asthma ...
notes on morgellons syndrome - Institute for Molecular Medicine
... Considerations (http://www.immed.org/). Ask your physician if certain supplements may interfere with medications that you are currently taking. 4. Lipid Replacement Therapy is important for fatigue and mitochondrial function. The Institute for Molecular Medicine has conducted several clinical trials ...
... Considerations (http://www.immed.org/). Ask your physician if certain supplements may interfere with medications that you are currently taking. 4. Lipid Replacement Therapy is important for fatigue and mitochondrial function. The Institute for Molecular Medicine has conducted several clinical trials ...
exercising during haemodialysis: the acute effects on markers of
... the control group patients rested throughout HD. In the exercise group, 60 minutes after the commencement of HD, patients cycled for 30 min at a “somewhat hard” intensity (rating of perceived exertion 13). Circulating concentrations of IL-6, IL-10, IL-1ra and TNF-α were measured using ELISA at the f ...
... the control group patients rested throughout HD. In the exercise group, 60 minutes after the commencement of HD, patients cycled for 30 min at a “somewhat hard” intensity (rating of perceived exertion 13). Circulating concentrations of IL-6, IL-10, IL-1ra and TNF-α were measured using ELISA at the f ...
Dermaroller for management of acne scars
... Management of atrophic acne scar in dark skin types were difficult. The standard treatments in white skin (Fitzpatrick skin type I,II) included dermabrasion, chemical peels, carbondioxide or erbium laser resurfacing. 3,4,5,6 Even in white skin patients results from these treatments were far from sat ...
... Management of atrophic acne scar in dark skin types were difficult. The standard treatments in white skin (Fitzpatrick skin type I,II) included dermabrasion, chemical peels, carbondioxide or erbium laser resurfacing. 3,4,5,6 Even in white skin patients results from these treatments were far from sat ...
Last Review Status/Date
... The oral use of sildenafil citrate is contraindicated in patients who are using any form of organic nitrate, either regularly or intermittently. Sildenafil citrate potentiates the hypotensive effect of nitrates. This potentiation is thought to result from the combined effects of nitrates and sildena ...
... The oral use of sildenafil citrate is contraindicated in patients who are using any form of organic nitrate, either regularly or intermittently. Sildenafil citrate potentiates the hypotensive effect of nitrates. This potentiation is thought to result from the combined effects of nitrates and sildena ...
No Effect of the Altered Peptide Ligand NBI-6024 on
... OBJECTIVE — This randomized, four-arm, placebo-controlled, dose-ranging phase 2 trial was conducted to determine whether repeated subcutaneous injections of the altered peptide ligand, NBI-6024, designed to inhibit autoreactive T-cells, improves -cell function in patients with recently diagnosed ty ...
... OBJECTIVE — This randomized, four-arm, placebo-controlled, dose-ranging phase 2 trial was conducted to determine whether repeated subcutaneous injections of the altered peptide ligand, NBI-6024, designed to inhibit autoreactive T-cells, improves -cell function in patients with recently diagnosed ty ...
Low Dose Naltrexone
... to treat a number of different “EndorphinDeficiency states”. Dr. Thomas Hilgers, a Professor in Obstetrics and Gynaecology from Creighton University, Omaha, Nebraska has used Naltrexone since 1990 to enhance the natural Endorphin surge and improve fertility rates in his Infertility Treatment program ...
... to treat a number of different “EndorphinDeficiency states”. Dr. Thomas Hilgers, a Professor in Obstetrics and Gynaecology from Creighton University, Omaha, Nebraska has used Naltrexone since 1990 to enhance the natural Endorphin surge and improve fertility rates in his Infertility Treatment program ...
review request for
... As initial trial (up to 12 weeks) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and the clinical presentation is not consistent with other polyneuropathies (for example, IgM neuropathy, hereditary neuropathy, diabetic neuropathy) (Please check the following that apply): Proximal muscl ...
... As initial trial (up to 12 weeks) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and the clinical presentation is not consistent with other polyneuropathies (for example, IgM neuropathy, hereditary neuropathy, diabetic neuropathy) (Please check the following that apply): Proximal muscl ...
ppt slides
... What We Have and What We Need We have Efficacy trials that determine whether an intervention produces a specified result(s) under well controlled conditions in a selected population – includes randomized controlled trials (RCTs) We need Effectiveness trials that measure outcomes of an intervention ...
... What We Have and What We Need We have Efficacy trials that determine whether an intervention produces a specified result(s) under well controlled conditions in a selected population – includes randomized controlled trials (RCTs) We need Effectiveness trials that measure outcomes of an intervention ...
Confirmation of association between multiple sclerosis and CYP27B1
... available for the included individuals.22 Several studies show that MS patients have lower levels of 25-OHD3 compared with controls.11 In an Australian study, low levels of 25-OHD3 could be linked to increased disability, likely caused by decreased sun exposure due to disability.23 It has also been ...
... available for the included individuals.22 Several studies show that MS patients have lower levels of 25-OHD3 compared with controls.11 In an Australian study, low levels of 25-OHD3 could be linked to increased disability, likely caused by decreased sun exposure due to disability.23 It has also been ...
Antibiotics for Acute Exacerbation Management
... with shortness of breath due to exertion, and cough sputum production that is sometimes also present. Patients typically seek medical attention because of chronic respiratory symptoms or an exacerbation of their disease1 • In Stage III: Severe COPD, an exacerbation is characterized by further worsen ...
... with shortness of breath due to exertion, and cough sputum production that is sometimes also present. Patients typically seek medical attention because of chronic respiratory symptoms or an exacerbation of their disease1 • In Stage III: Severe COPD, an exacerbation is characterized by further worsen ...
Folliculitis decalvans
... Folliculitis decalvans What is folliculitis decalvans? Folliculitis decalvans is a type of scarring hair loss that presents with pustules within the scalp. What causes folliculitis decalvans? The cause of folliculitis decalvans is unknown. Staphylococcus Aureus, a type of bacteria, is frequently fou ...
... Folliculitis decalvans What is folliculitis decalvans? Folliculitis decalvans is a type of scarring hair loss that presents with pustules within the scalp. What causes folliculitis decalvans? The cause of folliculitis decalvans is unknown. Staphylococcus Aureus, a type of bacteria, is frequently fou ...
American Uveitis Society: Birdshot Retinochoroidopathy
... appears to be a general trend toward more aggressive, therapy, there are widely differing views on the subject. As with all such conditions, the decision of when and how to treat is something all patients should discuss frankly with their treating physician. When treatment is decided upon, typically ...
... appears to be a general trend toward more aggressive, therapy, there are widely differing views on the subject. As with all such conditions, the decision of when and how to treat is something all patients should discuss frankly with their treating physician. When treatment is decided upon, typically ...
Professional Practice Guideline 10 `Antipsychotic medications as a
... stated by Professor Subee Banerjee in a report to United Kingdom Minister of State for Care Services: In reviewing the evidence, these drugs appear to have only a limited positive effect in treating these symptoms but can cause significant harm to people with dementia. Clearly, some people do benefi ...
... stated by Professor Subee Banerjee in a report to United Kingdom Minister of State for Care Services: In reviewing the evidence, these drugs appear to have only a limited positive effect in treating these symptoms but can cause significant harm to people with dementia. Clearly, some people do benefi ...
The empirical status of cognitive-behavioral therapy: A review of
... included the term cognitive therapy since this form of treatment typically incorporates behavioral interventions. The resulting list of articles and book chapters was retrieved and reviewed. Additional meta-analyses were identified in the texts of these reviews and a second series of articles and bo ...
... included the term cognitive therapy since this form of treatment typically incorporates behavioral interventions. The resulting list of articles and book chapters was retrieved and reviewed. Additional meta-analyses were identified in the texts of these reviews and a second series of articles and bo ...
and treatments
... B) Does the changing status of the underlying clinical condition over time (characteristic of most psychiatric disorders) affect the subsequent course and response to treatment C) Crossover studies may be most useful in chronic stable conditions where within subject variation is less than between su ...
... B) Does the changing status of the underlying clinical condition over time (characteristic of most psychiatric disorders) affect the subsequent course and response to treatment C) Crossover studies may be most useful in chronic stable conditions where within subject variation is less than between su ...
brain volume loss
... Assessing brain shrinkage is increasingly becoming an important consideration in monitoring RMS treatment ...
... Assessing brain shrinkage is increasingly becoming an important consideration in monitoring RMS treatment ...
Draft guideline on the development of new medicinal products for
... 4.1.4. UC in remission ................................................................................................. 5 ...
... 4.1.4. UC in remission ................................................................................................. 5 ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.